RETA
Retatrutide
Triple Agonist Peptide
Retatrutide is a groundbreaking triple agonist that targets GLP-1, GIP, and glucagon receptors simultaneously for unprecedented metabolic optimization.
Key Benefits
- Significant weight loss support
- Enhanced metabolic rate and efficiency
- Improved body composition
- Blood sugar regulation
- Reduced appetite and cravings
- Cardiovascular health benefits
Recommended Use
Start low and titrate slowly. Typical range: 1-12mg weekly via subcutaneous injection. Follow gradual dose escalation protocol.